Evidence map›Paper›PMID 26861587›Full record

ArticleScientific reports2016

Variation in susceptibility of African Plasmodium falciparum malaria parasites to TEP1 mediated killing in Anopheles gambiae mosquitoes.

Maarten Eldering, Isabelle Morlais, Geert-Jan van Gemert, Marga van de Vegte-Bolmer, Wouter Graumans, Rianne Siebelink-Stoter, Martijn Vos, Luc Abate, Will Roeffen, Teun Bousema and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Late sporogonic stages ofbioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Late sporogonic stages ofFrontiers in cellular and infection microbiology · 2024
    Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. PIMMS43 is required for malaria parasite immune evasion and sporogonic development in the mosquito vector.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 4 countries.

Maarten ElderingDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Isabelle MorlaisUMR MIVEGEC UM1-CNRS 5290-IRD 224, Institut de Recherche pour le Développement, Montpellier cedex, France.
Geert-Jan van GemertDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Marga van de Vegte-BolmerDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Wouter GraumansDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Rianne Siebelink-StoterDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Martijn VosDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Luc AbateUMR MIVEGEC UM1-CNRS 5290-IRD 224, Institut de Recherche pour le Développement, Montpellier cedex, France.
Will RoeffenDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Teun BousemaDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Elena A LevashinaVector Biology Unit, Max Planck Institute for Infection Biology, Berlin, Germany.
Robert W SauerweinDepartment of Medical Microbiology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLInstitut de Recherche pour le Développement · FRMaladies Infectieuses et Vecteurs: Écologie, Génétique, Évolution et Contrôle · FRMax Planck Institute for Infection Biology · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anopheles gambiae s.s. mosquitoes are efficient vectors for Plasmodium falciparum, although variation exists in their susceptibility to infection. This variation depends partly on the thioester-containing protein 1 (TEP1) and TEP depletion results in significantly elevated numbers of oocysts in susceptible and resistant mosquitoes. Polymorphism in the Plasmodium gene coding for the surface protein Pfs47 modulates resistance of some parasite laboratory strains to TEP1-mediated killing. Here, we examined resistance of P. falciparum isolates of African origin (NF54, NF165 and NF166) to TEP1-mediated killing in a susceptible Ngousso and a refractory L3-5 strain of A. gambiae. All parasite clones successfully developed in susceptible mosquitoes with limited evidence for an impact of TEP1 on transmission efficiency. In contrast, NF166 and NF165 oocyst densities were strongly reduced in refractory mosquitoes and TEP1 silencing significantly increased oocyst densities. Our results reveal differences between African P. falciparum strains in their capacity to evade TEP1-mediated killing in resistant mosquitoes. There was no significant correlation between Pfs47 genotype and resistance of a given P. falciparum isolate for TEP1 killing. These data suggest that polymorphisms in this locus are not the sole mediators of immune evasion of African malaria parasites.

Indexed as

AnimalsAnophelesDisease SusceptibilityGene SilencingImmunoblottingInsect ProteinsInsect VectorsMembrane GlycoproteinsMutation, MissenseOocystsPlasmodium falciparumPolymerase Chain ReactionPolymorphism, Single NucleotideProtozoan ProteinsSequence Analysis, DNAInsect ProteinsMembrane GlycoproteinsPfs47 protein, Plasmodium falciparumProtozoan ProteinsTEP1 protein, Anopheles gambiae

Identifiers

PMID26861587
PMCPMC4748223
OpenAlexW2294825264

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.